» Articles » PMID: 30374329

Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms

Overview
Specialty Endocrinology
Date 2018 Oct 31
PMID 30374329
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Exercise training ameliorates nonalcoholic fatty liver disease (NAFLD) as well as obesity and metabolic syndrome. Although it is difficult to eliminate the effects of body weight reduction and increased energy expenditure-some pleiotropic effects of exercise training-a number of studies involving either aerobic exercise training or resistance training programs showed ameliorations in NAFLD that are independent of the improvements in obesity and insulin resistance. studies have identified effects of exercise training on the liver, which may help to explain the "direct" or "independent" effect of exercise training on NAFLD. Exercise training increases peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) expression, improves mitochondrial function and leads to reduced hepatic steatosis, inflammation, fibrosis, and tumor genesis. Crosstalk between the liver and adipose tissue, skeletal muscle and the microbiome is also a possible mechanism for the effect of exercise training on NAFLD. Although numerous studies have reported benefits of exercise training on NAFLD, the optimal duration and intensity of exercise for the prevention or treatment of NAFLD have not been established. Maintaining adherence of patients with NAFLD to exercise training regimes is another issue to be resolved. The use of comprehensive analytical approaches to identify biomarkers such as hepatokines that specifically reflect the effect of exercise training on liver functions might help to monitor the effect of exercise on NAFLD, and thereby improve adherence of these patients to exercise training. Exercise training is a robust approach for alleviating the pathogenesis of NAFLD, although further clinical and experimental studies are required.

Citing Articles

Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Rajewski P, Ciescinski J, Rajewski P, Suwala S, Rajewska A, Potasz M Biomedicines. 2025; 13(1).

PMID: 39857800 PMC: 11760440. DOI: 10.3390/biomedicines13010217.


Rate and Associated Factors of Fatigue in Chinese Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Survey.

Du X, Hu J, Xue J, Zhuang Y, Tang X, Xu Z Int J Gen Med. 2024; 17:2945-2953.

PMID: 38984071 PMC: 11231026. DOI: 10.2147/IJGM.S466980.


Beneficial Effects of High-Intensity Interval Training and Dietary Changes Intervention on Hepatic Fat Accumulation in HFD-Induced Obese Rats.

Yuan X, Xiang M, Ping Y, Zhang P, Liu Y, Liu X Physiol Res. 2024; 73(2):273-284.

PMID: 38710057 PMC: 11081183.


Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods.

Yuan J, Zhang J, Luo Q, Peng L Sci Rep. 2024; 14(1):2709.

PMID: 38302636 PMC: 10834579. DOI: 10.1038/s41598-024-53112-1.


Effect of aerobic exercise on GRP78 and ATF6 expressions in mice with non-alcoholic fatty liver disease.

Li J, Huang L, Xiong W, Gu C, Zhang S, Xue X Sports Med Health Sci. 2023; 5(2):112-119.

PMID: 37424531 PMC: 10323921. DOI: 10.1016/j.smhs.2022.11.002.


References
1.
Hara H, Uchida S, Yoshimura H, Aoki M, Toyoda Y, Sakai Y . Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration. Biochim Biophys Acta. 2000; 1492(1):31-44. DOI: 10.1016/s0167-4781(00)00056-7. View

2.
Peter A, Kantartzis K, Machann J, Schick F, Staiger H, Machicao F . Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes. 2010; 59(12):3167-73. PMC: 2992779. DOI: 10.2337/db10-0179. View

3.
Linden M, Fletcher J, Morris E, Meers G, Kearney M, Crissey J . Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats. Am J Physiol Endocrinol Metab. 2013; 306(3):E300-10. PMC: 3920010. DOI: 10.1152/ajpendo.00427.2013. View

4.
Kerr J, Anderson C, Lippman S . Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017; 18(8):e457-e471. PMC: 10441558. DOI: 10.1016/S1470-2045(17)30411-4. View

5.
Matsubara M, Maruoka S, Katayose S . Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol. 2002; 147(2):173-80. DOI: 10.1530/eje.0.1470173. View